Local targets for immune therapy to cancer: Tumor draining lymph nodes and tumor microenvironment
- 16 August 2012
- journal article
- review article
- Published by Wiley in International Journal of Cancer
- Vol. 132 (9) , 1971-1976
Abstract
In recent years, it has become apparent that immunoregulatory processes influence cancer development. The key players in tumor progression are mainly present in the microenvironment of the tumor and the draining lymph nodes. Interventions aimed at shifting tumor‐promoting actions toward effective tumor‐eradicating immunity are thus foremost required locally. As immune‐modulating therapy has been shown to cause many adverse side effects when administered systemically, we strongly advocate the further development of local treatment for cancer immunotherapy.Keywords
This publication has 67 references indexed in Scilit:
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and HumansScience, 2011
- Endogenous T Cell Responses to Antigens Expressed in Lung Adenocarcinomas Delay Malignant Tumor ProgressionCancer Cell, 2011
- Tumor masses support naive T cell infiltration, activation, and differentiation into effectorsJournal of Experimental Medicine, 2010
- Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in miceJournal of Clinical Investigation, 2010
- Foxp3+ T Cells Induce Perforin-Dependent Dendritic Cell Death in Tumor-Draining Lymph NodesImmunity, 2010
- Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonistsClinical and Experimental Immunology, 2009
- Regulated Expression of a Tumor-Associated Antigen Reveals Multiple Levels of T-Cell Tolerance in a Mouse Model of Lung CancerCancer Research, 2008
- Immunological aspects of cancer chemotherapyNature Reviews Immunology, 2008
- Sentinel-Node Biopsy or Nodal Observation in MelanomaNew England Journal of Medicine, 2006
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002